1-3 of 3
Mari Kannagi, MD
Close
Sort by
Journal Articles

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

Motoaki Shiratsuchi, MDPhD, Tetsuya Fukuda, MD PhD, Tadafumi Iino, MD PhD, Atsuhiko Hasegawa, PhD, Jun-ichirou Yasunaga, MD PhD, Ken Watanabe, MD PhD, Akie Hirata, MD PhD, Hayato Utsunomiya, MD, Hirofumi Ohno, MD, Takashi Ishida, MD PhD, Koichi Akashi, MD PhD, Masao Matsuoka, MDPhD, Mari Kannagi, MD PhD, Youko Suehiro, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1649.
https://doi.org/10.1182/blood-2018-99-113315
Published: 2018
Journal Articles

A Therapeutic Vaccine In Adult T-Cell Leukemia Patients With Autologous Dendritic Cells Pulsed With Peptides Corresponding To Tax-Specific Cytotoxic T Lymphocyte Epitopes

Tadafumi Iino, MD, Youko Suehiro, MD, PhD, Atsuhiko Hasegawa, PhD, Nobukazu Watanabe, MD, PhD, Ryuji Tanosaki, MD, PhD, Atae Utsunomiya, M.D., PhD, Masao Matsuoka, MD, PhD, Takanori Teshima, MD, PhD, Koichi Akashi, MD, PhD, Naokuni Uike, MD, PhD, Jun Okamura, MD, PhD, Mari Kannagi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5130.
https://doi.org/10.1182/blood.V122.21.5130.5130
Published: 2013
Journal Articles

Durable Remission with Decreased HTLV-I Proviral Load after Reduced-Intensity Stem Cell Transplantation (RIST) in Patients with Adult T-Cell Leukemia/Lymphoma (ATL).

Ryuji Tanosaki, MD, Kisato Nosaka, MD, Shin Mineishi, MD, Shin-ichiro Mori, MD, Sung-Won Kim, MD, Masahiro Kami, MD, Mari Kannagi, MD, Shunro Sonoda, MD, Jun Okamura, MD, Takahiro Fukuda, MD, Kensei Tobinai, MD, Yoichi Takaue, MD
Journal: Blood
Blood (2005) 106 (11): 3347.
https://doi.org/10.1182/blood.V106.11.3347.3347
Published: 2005